6.24
price up icon54.07%   2.19
after-market Dopo l'orario di chiusura: 5.91 -0.33 -5.29%
loading
Precedente Chiudi:
$4.05
Aprire:
$6.3
Volume 24 ore:
83.49M
Relative Volume:
60.19
Capitalizzazione di mercato:
$11.73M
Reddito:
$15.66M
Utile/perdita netta:
$5.83M
Rapporto P/E:
-0.2612
EPS:
-23.8939
Flusso di cassa netto:
$466.20K
1 W Prestazione:
-59.79%
1M Prestazione:
-45.50%
6M Prestazione:
+20.23%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$5.66
$8.44
Intervallo di 1 settimana:
Value
$3.75
$17.19
Portata 52W:
Value
$2.90
$21.40

Neuphoria Therapeutics Inc Stock (NEUP) Company Profile

Name
Nome
Neuphoria Therapeutics Inc
Name
Telefono
781-439-5551
Name
Indirizzo
100 SUMMIT DR, BURLINGTON
Name
Dipendente
8
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
NEUP's Discussions on Twitter

Confronta NEUP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NEUP
Neuphoria Therapeutics Inc
6.24 9.55M 15.66M 5.83M 466.20K -23.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-09-28 Aggiornamento H.C. Wainwright Neutral → Buy
2023-09-28 Reiterato Maxim Group Buy
2022-01-10 Iniziato Berenberg Buy
2022-01-10 Iniziato Cantor Fitzgerald Overweight
2022-01-10 Iniziato Evercore ISI Outperform
2022-01-10 Iniziato H.C. Wainwright Buy
Mostra tutto

Neuphoria Therapeutics Inc Borsa (NEUP) Ultime notizie

pulisher
Oct 26, 2025

Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessTrade Volume Summary & Reliable Price Breakout Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Can Neuphoria Therapeutics Inc. stock hit analyst price targetsTrade Analysis Summary & Free High Return Stock Watch Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is Neuphoria Therapeutics Inc. stock attractive after correctionBear Alert & Real-Time Stock Movement Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Using AI based signals to follow Neuphoria Therapeutics Inc.2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Neuphoria Therapeutics Inc.’s volatility index tracking explainedPortfolio Profit Report & High Win Rate Trade Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Automated trading signals detected on Neuphoria Therapeutics Inc.Trade Volume Summary & Weekly High Return Forecasts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why hedge funds are buying Neuphoria Therapeutics Inc. stockInsider Selling & Stepwise Trade Execution Plans - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsTrade Exit Summary & Weekly High Potential Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Best Biotech Stocks To Keep An Eye OnOctober 25th - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 10:45:26 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Neuphoria Therapeutics Advances BNC-210 Trial with Prolonged Cash Runway - StocksToTrade

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 11:32:54 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why analysts upgrade Neuphoria Therapeutics Inc. stockTrade Entry Summary & Verified Short-Term Plans - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Can Neuphoria Therapeutics Inc. stock maintain operating marginsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Published on: 2025-10-25 19:04:06 - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Neuphoria Therapeutics Stock Gains Amid Phase 3 Trial Advances - StocksToTrade

Oct 25, 2025
pulisher
Oct 25, 2025

Neuphoria Therapeutics Advances Social Anxiety Drug in Key Phase 3 Trial - timothysykes.com

Oct 25, 2025

Neuphoria Therapeutics Inc Azioni (NEUP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):